Solvay Pharmaceuticals, Inc.

92 articles about Solvay Pharmaceuticals, Inc.

• Actinium Appoints Robert N. Daly, Ph.D. to Newly Created Role of Vice President, Head of Clinical Operations

  9/6/2018

  Industry veteran to lead and execute operations for pivotal Phase 3 SIERRA trial for Iomab-B.

• 

  Price Increase in EU Calls Comparisons Between Leadiant Biosciences and Martin Shkreli

  9/5/2018

  More than a year after Maryland-based Sigma-Tau Pharmaceuticals changed its name to Leadiant Biosciences, the newly-dubbed company is now being associated with a much darker name – that of jailed biotech entrepreneur Martin Shkreli.

• GeoVax Announces Appointment of David Dodd as Chairman, President and Chief Executive Officer

  8/14/2018

  GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that David A. Dodd has been appointed President and Chief Executive Officer, effective September 1, succeeding Robert McNally, PhD, who has announced his retirement.

• In Hearings, University of Minnesota Admits Problems in Solvay Pharmaceuticals, Inc.’s Schizophrenia Drug

  5/11/2015

• Former Solvay Pharmaceuticals, Inc. Chief Werner Cautreels, Ph.D. Takes Lead Role at Startup Selecta Biosciences, Inc.

  8/16/2010

• Eurand Names Former Solvay Pharmaceuticals, Inc. Executive Jean-Louis Anspach President of U.S. Pharmaceuticals Business

  6/16/2010

• Solvay Pharmaceuticals, Inc.'s 1st quarter 2010 Results

  5/11/2010

• Solvay Pharmaceuticals, Inc. Starts Buyback, Still Looking at Acquisitions; Shares will be Held, Not Cancelled

  2/16/2010

• Abbott Laboratories Completes Acquisition of Solvay Pharmaceuticals, Inc.

  2/16/2010

• Abbott Laboratories Buy of Solvay Pharmaceuticals, Inc. Drug Unit Wins EU Approval

  2/12/2010

• Malvern Instruments: Morphologi G3 "Adds New Dimension" To Solvay Pharmaceuticals, Inc. R&D

  2/9/2010

• Solvay Pharmaceuticals, Inc. Release: CREON(R) (Pancrelipase) Delayed-Release Capsules Significantly Improves Fat Absorption in Children with Cystic Fibrosis, Study in Clinical Therapeutics Reports

  2/5/2010

• EU Extends Review Deadline for Solvay Pharmaceuticals, Inc., Abbott Laboratories (JOBS) Deal

  1/22/2010

• Solvay Pharmaceuticals, Inc.'s CREON(R) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis

  10/15/2009

• Sinclair Pharma plc Acquires Flammazine, Flammacerium from Solvay Pharmaceuticals, Inc. for EUR 17.5 Million; Gets New CEO

  10/12/2009

• Solvay Pharmaceuticals, Inc.: Results Published In Journal of Cystic Fibrosis Confirm CREON(R) (pancrelipase) Delayed-Release Capsules Improves Fat Absorption in Patients With Cystic Fibrosis

  10/9/2009

• Solvay Pharmaceuticals, Inc. Sells Drug Unit to Abbott Laboratories (JOBS) for $6.6 Billion

  9/28/2009

• Nycomed May Up Solvay Pharmaceuticals, Inc. Bid as Sale Decision Looms

  9/25/2009

• Abbott Laboratories (JOBS) Joins Bidding for Solvay Pharmaceuticals, Inc. Drug Unit; Deal Could be Valued at $5.9 to $7.4 Billion

  9/25/2009

• Nycomed Makes 4-4.5 Billion Euro Solvay Pharmaceuticals, Inc. Bid Say Sources

  9/21/2009